Similar articles

• Iron chelation in thalassemia: mechanism of desferrioxamine action.

  Hershko C, Rachmilewitz EA. Hershko C, et al. Isr J Med Sci. 1978 Nov;14(11):1111-5. Isr J Med Sci. 1978. PMID: 750535
• Early iron chelation therapy in thalassemia major.

  Russo G, Romeo MA, Musumeci S, Schilirò G, Di Gregorio F. Russo G, et al. Haematologica. 1983 Jan-Feb;68(1):69-73. Haematologica. 1983. PMID: 6404710 No abstract available.
• [Changes in urinary iron in thalassemia major in relation to the administration of desferrioxamine].

  Esposito L, Ferrara M, Galdo Capotorti M. Esposito L, et al. Pediatria (Napoli). 1978 Mar 31;86(1):69-76. Pediatria (Napoli). 1978. PMID: 683795 Italian. No abstract available.
• Oral iron chelators.

  Nathan DG, Piomelli S. Nathan DG, et al. Semin Hematol. 1990 Apr;27(2):83-5. Semin Hematol. 1990. PMID: 2190320 Review. No abstract available.
• Chelation therapy in beta-thalassemia: the benefits and limitations of desferrioxamine.

  Giardina PJ, Grady RW. Giardina PJ, et al. Semin Hematol. 1995 Oct;32(4):304-12. Semin Hematol. 1995. PMID: 8560288 Review.